MIR3943

Across TCGA pan-cancer cohorts, MIR3943 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR3943 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher MIR3943 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3943 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

DLBC, STAD, and UCEC are the cancer types where MIR3943 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
STAD	OS	Tertile	III,IV	0.277	0.648	.018	36	view →
UCEC	DFS	Tertile	All	0.664	0.900	.005	36	view →
COAD	DFS	Tertile	II,III,IV	0.215	0.663	.018	18	view →
LIHC	DFS	Tertile	All	0.034	0.554	<.001	18	view →
LGG	OS	Tertile	All	0.981	0.885	.025	12	view →
LUSC	DFS	Tertile	All	0.314	0.647	.026	6	view →
ESCA	DFS	Tertile	All	0.326	0.547	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR3943–DLBC (OS)

Open the DLBC breakdown →